Aditxt (ADTX) Operating Income (2019 - 2026)
Aditxt (ADTX) recorded quarterly Operating Income of -$4.4 million in Q1 2026, up 6.59% quarter-over-quarter from -$4.7 million in Q4 2025, and up 22.22% on a YoY basis from -$3.6 million in Q1 2025.
Aditxt (ADTX) Operating Income (2019 - 2026) Analysis & Trends
Aditxt's Operating Income history runs 8 years deep, the most recent figure standing at -$4.4 million for Q1 2026.
- In Q1 2026, Operating Income rose 22.22% year-over-year to -$4.4 million; the TTM figure through Mar 2026 stood at -$18.3 million (up 16.46% YoY), while the FY2025 annual figure was -$19.6 million, up 29.76% from the prior year.
- Operating Income was -$4.4 million for Q1 2026 at Aditxt, up from -$4.7 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$3.1 million in Q3 2025 to a low of -$11.5 million in Q1 2024.
- Historically, Operating Income has averaged -$6.1 million across 5 years, with a median of -$5.8 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Operating Income jumped 65.82% in 2022, then tumbled 99.51% in 2024.
- A 5-year view of Operating Income shows it stood at -$8.2 million in 2022, then advanced by 3.04% to -$8.0 million in 2023, then increased by 28.93% to -$5.7 million in 2024, then climbed by 17.37% to -$4.7 million in 2025, then climbed by 6.59% to -$4.4 million in 2026.
- The last three Operating Income figures came in at -$4.4 million (Q1 2026), -$4.7 million (Q4 2025), and -$3.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | -4.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.36 Mn |
| Dec 31, 2025 | -4.67 Mn |
| Sep 30, 2025 | -3.14 Mn |
| Jun 30, 2025 | -6.15 Mn |
| Mar 31, 2025 | -5.61 Mn |
| Dec 31, 2024 | -5.65 Mn |
| Sep 30, 2024 | -4.70 Mn |
| Jun 30, 2024 | -5.98 Mn |
| Mar 31, 2024 | -11.54 Mn |
| Dec 31, 2023 | -7.95 Mn |
| Sep 30, 2023 | -8.10 Mn |
| Jun 30, 2023 | -4.23 Mn |
| Mar 31, 2023 | -5.78 Mn |
| Dec 31, 2022 | -8.20 Mn |
| Sep 30, 2022 | -5.39 Mn |
| Jun 30, 2022 | -5.77 Mn |
| Mar 31, 2022 | -6.12 Mn |
| Dec 31, 2021 | -23.99 Mn |
| Sep 30, 2021 | -6.07 Mn |
| Jun 30, 2021 | -5.78 Mn |